| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/04/2011 | CA2781314A1 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 08/04/2011 | CA2780432A1 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester |
| 08/04/2011 | CA2780421A1 Gamma secretase modulaters |
| 08/04/2011 | CA2770767A1 Bicyclic heteroaryl inhibitors of pde4 |
| 08/04/2011 | CA2761509A1 Triazine-aryl-bis-indoles and process for preparation thereof |
| 08/03/2011 | EP2351852A1 RNA interference mediating small RNA molecules |
| 08/03/2011 | EP2351847A1 Method for producing sophorose lipid |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351828A1 Methods and compositions for regulating biofilm development |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351764A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 08/03/2011 | EP2351757A1 Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof |
| 08/03/2011 | EP2351756A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351753A1 Phenanthroindolizidine derivative and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351752A1 PYRIDINE DERIVATIVE HAVING SUBSTITUTED HETERO RING AND SUBSTITUTED y-GLUTAMYLAMINO GROUP, AND ANTI-FUNGAL AGENT COMPRISING SAME |
| 08/03/2011 | EP2351751A1 Substituted pyrazolopyrimidines |
| 08/03/2011 | EP2351749A1 Carbamate compound or salt thereof |
| 08/03/2011 | EP2351748A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 08/03/2011 | EP2351746A1 The 1-butyl-2-hydroxyaralkyl piperazine derivatives and the uses as anti-depression medicine thereof |
| 08/03/2011 | EP2351744A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase |
| 08/03/2011 | EP2351743A1 Bicyclic compound |
| 08/03/2011 | EP2351742A1 Indazole derivative |
| 08/03/2011 | EP2351739A1 The 2-(4-substituted phenylamino) polysubstituted pyridine compounds as the inhibitors of non-nucleoside hiv reverse transcriptase, praparation methods and uses thereof |
| 08/03/2011 | EP2351737A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/03/2011 | EP2351732A2 Novel compound ramalin, and use thereof |
| 08/03/2011 | EP2351731A1 A group of amino substituted benzoyl derivatives and their preparation and their use |
| 08/03/2011 | EP2351730A1 Ethoxy diphenyl ethane derivates, preparation processes and uses thereof |
| 08/03/2011 | EP2351585A1 Anti-hepatitis c virus composition |
| 08/03/2011 | EP2351575A2 Novel uses of grs proteins or fragments thereof |
| 08/03/2011 | EP2351571A1 Protein phosphatase inhibitor |
| 08/03/2011 | EP2351570A1 An Antibiotic/Analgesic Formulation And a Method of Making This Formulation |
| 08/03/2011 | EP2351569A1 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| 08/03/2011 | EP2351568A2 Uses of dpp-iv inhibitors |
| 08/03/2011 | EP2351567A2 Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351565A1 Medicine for preventing or treating pain related to herpes zoster |
| 08/03/2011 | EP2351564A1 Methods of treating an inflammatory-related disease |
| 08/03/2011 | EP2351563A1 Agent for treatment of diabetes |
| 08/03/2011 | EP2351562A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
| 08/03/2011 | EP2351561A2 Novel methods and compositions for alleviating pain |
| 08/03/2011 | EP2351560A1 Treatment Of HCV infections with FTY720 |
| 08/03/2011 | EP2351559A2 Novel use of panduratin derivative or boesenbergia pandurata extract |
| 08/03/2011 | EP2351558A1 Therapeutic agent for tympanites in ruminant animal |
| 08/03/2011 | EP2351557A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom |
| 08/03/2011 | EP2351555A2 Abuse resistance opioid transdermal delivery device |
| 08/03/2011 | EP2351554A1 Enhanced stability phenylephrine liquid compositions |
| 08/03/2011 | EP2351491A1 Concentrated liquid diet |
| 08/03/2011 | EP2351486A1 Antimicrobial composition containing N(n-butyl)-1,2-benzisothiazolin-3-one |
| 08/03/2011 | EP2350665A1 Combined use of bendamustine, doxorubicin and bortezomib for the treatment of multiple myeloma |
| 08/03/2011 | EP2350664A1 Treatment of cancer using hypoxia activated prodrugs |
| 08/03/2011 | EP2350656A1 Methods and kits to identify invasive glioblastoma |
| 08/03/2011 | EP2350642A1 Na/k-atpase expression as an indicator for the treatment of cancer |
| 08/03/2011 | EP2350641A1 Method of treatment |
| 08/03/2011 | EP2350311A1 Diacylglycerol acyltransferase inhibitors |
| 08/03/2011 | EP2350283A2 Compounds and methods for the treatment of inflammatory diseases of the cns |
| 08/03/2011 | EP2350282A1 Increased expression of specific antigens |
| 08/03/2011 | EP2350281A1 Multiple exon skipping compositions for dmd |
| 08/03/2011 | EP2350280A1 Immunosuppression compound and treatment method |
| 08/03/2011 | EP2350279A2 Methods for treating eye disorders |
| 08/03/2011 | EP2350276A1 Syngr4 for target genes of cancer therapy and diagnosis |
| 08/03/2011 | EP2350264A2 Treatment of chronic inflammatory respiratory disorders |
| 08/03/2011 | EP2350263A1 Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions |
| 08/03/2011 | EP2350097A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/03/2011 | EP2350096A1 Methods of treating hepatic encephalopathy |
| 08/03/2011 | EP2350095A1 Fused ring thiophene dyes for imaging and therapy |
| 08/03/2011 | EP2350093A1 Substituted 4,5,6,7-tetrahydrothienopyridines as kcnq2/3 modulators for treating pain, epilepsy and urinary incontinence |
| 08/03/2011 | EP2350092A1 Methylene amines of thieno ý2,3-d¨pyrimidine and their use as adenosine a2a receptor antagonists |
| 08/03/2011 | EP2350091A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 08/03/2011 | EP2350090A2 Spiro-oxindole compounds and their use as therapeutic agents |
| 08/03/2011 | EP2350089A1 Protease inhibitors |
| 08/03/2011 | EP2350088A1 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
| 08/03/2011 | EP2350087A1 Regioselective reduction of fused pyrrolocarbazoles-5,7-diones |
| 08/03/2011 | EP2350086A2 Fused diimidazodiazepine compounds and methods of use and manufacture thereof |
| 08/03/2011 | EP2350085A1 Quinazolinone linked pyrroloý2,1 -c¨ý1.4¨benzodiazepine hybrids as potential anticancer agents and process forthe preparation thereof |
| 08/03/2011 | EP2350084A1 Tetra-aza-heterocycles as phosphatidylinositol-3-kinases (pi3-kinases) inhibitor |
| 08/03/2011 | EP2350083A1 Pyrido [5, 4-d]pyrimidines as cell proliferation inhibitors |
| 08/03/2011 | EP2350082A1 Choline and tromethamine salt of licofelone |
| 08/03/2011 | EP2350081A1 Imidazopyridazinecarbonitriles useful as kinase inhibitors |
| 08/03/2011 | EP2350080A1 Unsymmetrical pyrrolobenzodiazepine-dimers for treatment of proliferative diseases |
| 08/03/2011 | EP2350078A2 Compounds that expand hematopoietic stem cells |
| 08/03/2011 | EP2350077A1 Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| 08/03/2011 | EP2350076A2 Imidazoý1,2- ¨pyridinyl bisphosphonates |
| 08/03/2011 | EP2350075A1 Substituted imidazoý1,2b¨pyridazine compounds as trk kinase inhibitors |
| 08/03/2011 | EP2350073A1 3H-IMIDAZO[4,5-b]PYRIDINE-6-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS |
| 08/03/2011 | EP2350072A1 Substituted pyrazoloquinolines and derivatives thereof |
| 08/03/2011 | EP2350071A1 SUBSTITUTED PYRAZOLOÝ1,5-a¨PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS |
| 08/03/2011 | EP2350070A1 Pyridopyrimidinone inhibitors of pi3k and mtor |
| 08/03/2011 | EP2350068A2 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| 08/03/2011 | EP2350067A2 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 08/03/2011 | EP2350065A1 A novel polymorph of emtricitabine and a process for preparing of the same |
| 08/03/2011 | EP2350064A1 Compounds for inflammation and immune-related uses |
| 08/03/2011 | EP2350063A1 Therapeutic macrolide compounds and their use |
| 08/03/2011 | EP2350060A2 Melanocortin receptor agonists |
| 08/03/2011 | EP2350059A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 08/03/2011 | EP2350058A2 Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt |
| 08/03/2011 | EP2350057A2 Novel salts of sunitinib |
| 08/03/2011 | EP2350054A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/03/2011 | EP2350053A2 Soluble mtor complexes and modulators thereof |
| 08/03/2011 | EP2350052A2 Antiproliferative compounds |